CXCR4 and cervical cancer: Although there are currently no studies demonstrating the role of 68Ga-Pentixafor in cervical cancer, it appears that CXCR4-targeted imaging could potentially be used to prognosticate patients as well as to select patients who may benefit from therapies targeting CXCR4.